Academic expertise, real world experience
PhenoPath pathologists are nationally recognized thought leaders in many areas of pathology. The team actively publishes and they often serve as invited speakers at regional, national, and international pathology workshops and professional meetings. Our pathologists are backed by technologists with years of experience in histology, IHC, flow cytometry, and molecular testing. Because we are dedicated to clinical excellence, you can be assured of accurate, up-to-date and authoritative case reporting, incorporating the latest developments in the classification and analysis of tumors. We are readily accessible via email or telephone to discuss any aspect of your case.
Specializing in: Hematopathology
Board Certifications: Anatomic Pathology, Hematology
Fellowship: Hematopathology, Yale University/Yale New Haven Hospital, New Haven, CT
Residency: Anatomic Pathology, Yale University/Yale New Haven Hospital, New Haven, CT
Medical Schools: University of Texas Southwestern Medical Center at Dallas (UTSW)
Board Certifications: Anatomic and Clinical Pathology | Hematology
Fellowship: Hematopathology, New York University Medical Center, New York, NY
Residency: Anatomic and Clinical Pathology, Baptist Health System, Birmingham, AL
Medical School: Zhanjiang Medical College*, Zhanjiang, China
* since renamed Guangdong Medical University
Board Certifications: Anatomic and Clinical Pathology and Molecular Diagnostics
Fellowship: Immunohistochemistry, PhenoPath Laboratories – Seattle, WA
Residency: University of Washington, School of Medicine – Seattle, WA
Medical School: University of Pennsylvania School of Medicine – Philadelphia, PA
Specializing in: Genitourinary and Placental Pathology
Board Certifications: Anatomic and Clinical Pathology
Fellowships: Genitourinary Pathology, Indiana
University – Indianapolis, IN; Surgical Pathology and Placental
Pathology, University of California San Diego – San Diego, CA
Residency: Anatomic and Clinical Pathology, University of California San Diego – San Diego, CA
Medical School: University of California San Diego School of Medicine – San Diego, CA
Medical Director
Board Certifications: Anatomic Pathology and Hematopathology
Fellowship: Hematopathology, University of Washington Affiliated Hospitals – Seattle, WA
Residency: University of Washington Affiliated Hospitals – Seattle, WA
Medical School: University of Washington – Seattle, WA
Dr Dolphine Oda, BDS (DDS), MSc is board certified in oral pathology. She received her BDS (DDS) in dentistry from the University of Baghdad, Iraq, and her MSc in surgical pathology and anatomic pathology from the University of Manitoba, School of Medicine, Winnipeg, Canada. She then served as a postdoctoral fellow in cancer research at the University of California, San Francisco School of Medicine. Until recently, Dr Oda was a professor of oral pathology in the Department of Oral and Maxillofacial Surgery and the director of the University of Washington’sOral Pathology Biopsy Service.
Dr Oda brings extensive research experience to our team, including epithelial (oral, pancreatic, and gallbladder) cell carcinogenesis, cell culture, human papillomavirus (HPV) and oral cancer, and chemical carcinogenesis. She has over 140 peer-reviewed publications and authored the popular online series Case of the Month, an interactive monthly publication for dental practitioners. She is also a member of several professional societies, including the American Academy of Oral Pathology; the International Association for Dental Research, Experimental Pathology Group; the International Association of Oral Pathologists; and the American Dental Association.
Board Certification: Oral Pathology
Fellowship: Cancer research, University of California, San Francisco School of Medicine
Medical School: Surgical pathology, Anatomic pathology, University of Manitoba School of Medicine, Winnipeg, Canada
Director of Operations and Cytogenetics
Board Certifications: Clinical Cytogentics
Fellowship: Clinical Cytogenetics, University of Washington Medical Center – Seattle, WA
Doctor of Philosophy: Molecular Pathology, University of Washington – Seattle, WA
CRO Sr. Scientist
Dr. Galina Strizheva leads the development and execution of preclinical and clinical research projects, designs new assays and implements new methodologies. She provides scientific and technical expertise and assistance to variety of CRO projects. She also leads the assay validation process and collaborates closely with our laboratory teams.
Dr. Strizheva is an accomplished scientist with over 18 years of experience as a researcher, scientific support and project leader within the commercial, clinical and research organizations in the US and Russian Federation, with expertise in immunology, molecular and cellular biology. She received her MD in Research (Medical Biochemistry, Molecular and Cell Biology) from the Russian State Medical University and performed her graduate project at Fox Chase Cancer Center. Dr. Strizheva continued her education in the US and received her MSc in Pharmacology and Physiology from Saint Louis School of Medicine. For the past six years, Dr. Strizheva worked within CRO organizations leading cell biology and immunology projects and covering assay development and validation for safety of biologics, tumor tolerance, and immune checkpoint modulators. Prior to that, Dr. Strizheva provided consultations, coaching and troubleshooting to the customers interested in IHC, Flow Cytometry, FISH and CISH research, and diagnostic products in the role of the Support Scientist at Life Technologies Corporation (now part of the Thermo Fisher Corp.). At the beginning of her career, Dr. Strizheva briefly worked in Investigative Toxicology department at Amgen and cytogenetics clinical labs at Cardinal Glennon Children’s Hospital and at Russian Children's Clinical Hospital.
Publications (limited selection)
Strizheva G, Randhawa A, Mulligan J, O’Day. Development of an in vitro pre-clinical cellular assay to predict induction of Cytokine Storm by therapeutic antibodies. The Journal of Immunology. 188, 125.16, 2012.
Strizheva G, Carsillo T, Kruger W, Sullivan E, Ryu J, Henske P. The Spectrum of Mutations in TSC1 and TSC2 in Women with Tuberous Sclerosis and Lymphangioleiomyomatosis. Am J Respir. Crit. Care Med. vol. 163 no. 1 253-258. January, 2001.
Khare L, Strizheva G, Bailey J, Au K, Northrup H, Smith M, Smalley S, Henske E. A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex. J Med Genet. 38:347–349, 2001.
Specializing in: Surgical pathology; Molecular pathology
Board Certifications: Anatomic and Clinical Pathology | Molecular Genetic Pathology
Fellowship: Surgical Pathology | Molecular Genetic Pathology | Washington University Department of Pathology and Immunology - St. Louis, MO
Residency: Anatomic and Clinical Pathology | Yale Department of Pathology and Laboratory Medicine - New Haven, CT
Medical School: Vanderbilt University School of Medicine - Nashville, TN
Specializing in: Hematopathology; molecular oathology
Board Certifications: Anatomic Pathology; Hematopathology
Fellowship: Hematopathology - Brigham and Women's Hospital - Boston, MA | Surgical Pathology / Cardiopulmonary and Renal pathology - Brigham and Women’s Hospital - Boston, MA | Gastrointestinal pathology - Massachusetts General Hospital - Boston, MA
Residency: Anatomic Pathology - Brigham and Women's Hospital - Boston, MA
Medical School: Mayo Clinic College of Medicine and Science - Rochester, MN • PhD in Molecular Neurosciences – Mayo Graduate School